Dr. Cunningham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 2014 - 2017
- Harvard Medical SchoolClass of 2014
Certifications & Licensure
- MA State Medical License 2014 - 2027
- NH State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Pulmonary congestion on lung ultrasound in ambulatory patients with heart failure and preserved ejection fraction.Elke Platz, Kirsty McDowell, Deepak K Gupta, Brian Claggett, Alice Brennan
Journal of Cardiac Failure. 2025-03-05 - Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.Jonathan W Cunningham, Safia Chatur, Brian L Claggett, Muthiah Vaduganathan, Akshay S Desai
JAMA Cardiology. 2025-02-26 - 6 citationsFinerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial.Akshay S Desai, Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac, Pardeep S Jhund
Journal of the American College of Cardiology. 2025-01-21
Press Mentions
- FINEARTS-HF Analysis Shows Finerenone Reduces Worsening HF Symptoms in OutpatientsMarch 5th, 2025
- Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HFMarch 3rd, 2025
- State-of-The Art Review Discusses Risk and Potential of AI in Clinical TrialsNovember 20th, 2024
- Join now to see all
Grant Support
- Effect of Neprilysin Inhibition on Myocardial Interstitial FibrosisBRIGHAM AND WOMEN'S HOSPITAL2024–2029
- Effect of Neprilysin Inhibition on Myocardial Interstitial FibrosisBRIGHAM AND WOMEN'S HOSPITAL2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: